Join
Live feed
·
SECFilingvia Quantisnow
Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
ARDS· Aridis Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARDS (Aridis Pharmaceuticals Inc.) and more on Quantisnow.